Diabetes is predicted to affect 700 million people by the year 2045. Despite the potential
benefits for diabetics, curcumin's low bioavailability significantly reduces its utility. However …

Diabetes is a metabolic disease with multifactorial causes which requires lifelong drug
therapy as well as lifestyle changes. There is now growing scientific evidence to support the …

Diabetes mellitus (DM) is an ensemble of metabolic conditions that have reached pandemic
proportions worldwide. Pathology's multifactorial nature makes patient management …

Type 2 diabetes is a chronic condition in which cells have reduced insulin signalling,
leading to hyperglycemia and long‐term complications, including heart, kidney and liver …

Curcumin is the yellow-colored bioactive constituent of the perennial plant, Curcuma longa
L., which possesses a wide range of physiological and pharmacological properties such as …

Curcumin is the major polyphenolic constituent of an indigenous herb, Curcuma longa,
found to have a wide range of applications right from its kitchen use as a spicy ingredient to …

Turmeric or Curcuma longa is a natural product, whose medicinal properties have been
extensively studied and a wide variety of therapeutic effects on several diseases such as …

Type 2 diabetes mellitus (T2DM) is an ensemble of metabolic diseases that has reached
pandemic dimensions all over the world. The multifactorial nature of the pathology makes …

Objectives Nanotechnology-based drug delivery systems can resolve the poor
bioavailability issue allied with curcumin. The therapeutic potential of curcumin can be …

Diabetes mellitus is an extremely prevalent endocrine disease and a major global public
health concern. Diabetic complications, such as retinopathy, nephropathy, neuropathy and …